Hello Friends! Are you looking to invest in the stock market, or have you already invested? Would you like to know the predictions regarding the potential fluctuations in your shares? If so, you have landed on exactly the right page. On this page, you will find information regarding Senores Pharmaceuticals owner, Senores Pharmaceuticals IPO, Senores pharmaceuticals share price history, Senores pharmaceuticals share price screener, Senores share price NSE, Senores pharmaceuticals share price target 2026, and much more. Furthermore, this page provides details on Senores Phamaceuticals‘s share price targets 2026, 2027, 2028, 2029, 2030, 2040, and beyond.
Senores Phamaceuticals Company Information
| Founded |
2017 |
| Headquarters | India |
| Number of employees | 194 (2025) |
| Subsidiaries | Senores Pharmaceuticals, Inc., Havix Group Inc., Apnar Pharma Private Limited, Renosen Ventures Inc. |
Senores Phamaceuticals Share Price Target Overview
- Current Price – 1,143.90
- Open – 1,150.15
- High – 1,173.80
- Low – 1,141.05
- Mkt cap – 5.26KCr
- P/E ratio – 43.30
- 52-wk high – 1,194.40
- 52-wk low – 500.00
- Dividend – N/A
- Qtrly div amt – N/A
Senores Phamaceuticals Share Price Chart
Senores Phamaceuticals Share Price Target Tomorrow (Prediction)
| Senores Phamaceuticals Share Price Target Years | Senores Phamaceuticals Share Price Target |
| 2026 | ₹1200 |
| 2027 | ₹1850 |
| 2028 | ₹2500 |
| 2029 | ₹3150 |
| 2030 | ₹3850 |
Senores Phamaceuticals Share Price Target 2026
The target for Senores Phamaceuticals’s share price in 2026 is projected to range between ₹1150 and ₹1200. As of the end of May 2026, Senores Phamaceuticals’s share price stood at ₹1,143.90. Compared to the previous year, Senores Phamaceuticals’s share price has witnessed an increase this year.
Senores Phamaceuticals Share Price Target 2027
The target for Senores Phamaceuticals’s share price in 2027 is projected to range between ₹1800 and ₹1850. On 26 May 2026, Senores Phamaceuticals Share price NSE is 1,143.90 INR. Compared to last year, no significant difference has been observed in the share price of Senores Phamaceuticals. The share price has increased by approximately 640-650 rupees.
Senores Phamaceuticals Share Price Target 2030
The target for Senores Phamaceuticals’s share price in 2030 is projected to range between ₹3800 and ₹3850. Over the past several years, the company has generated substantial profits, and investors, too, have earned handsome returns proportionate to their shareholdings. We remain optimistic that the company will continue to generate profits in the future, thereby ensuring continued returns for its investors.
Read Also:- Seshaasai Technologies Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Senores Phamaceuticals Shareholding Pattern
| Promoter | 45.82% |
| FII | 3.54% |
| DII | 4.54% |
| Retails & Others | 40.93% |
| Mutual Funds | 5.07% |
Income Statement Of Senores Phamaceuticals
|
All values in INR
|
Jun 2025
|
Sep 2025
|
Dec 2025
|
Mar 2026
|
|---|---|---|---|---|
|
Revenue
|
1.38B
|
1.53B
|
1.65B
|
1.75B
|
|
Cost of goods sold
|
613.60M
|
570.80M
|
670.20M
|
662.20M
|
|
Cost of revenue
|
613.60M
|
570.80M
|
670.20M
|
662.20M
|
|
Research and development expenses
|
–
|
–
|
–
|
–
|
|
Total research and development expenses
|
–
|
–
|
–
|
–
|
|
Selling, general, and admin expenses
|
216.50M
|
296.30M
|
306.60M
|
303.20M
|
|
Operating expense
|
484.50M
|
548.70M
|
517.00M
|
707.80M
|
|
Total operating expenses
|
1.10B
|
1.12B
|
1.19B
|
1.37B
|
|
Operating income
|
281.80M
|
414.10M
|
461.40M
|
381.90M
|
|
Other non operating income
|
33.50M
|
54.10M
|
37.90M
|
176.70M
|
|
EBT including unusual items
|
264.90M
|
406.30M
|
446.00M
|
474.00M
|
|
EBT excluding unusual items
|
264.90M
|
406.30M
|
446.00M
|
474.00M
|
|
Income tax expense
|
53.10M
|
105.10M
|
110.20M
|
107.30M
|
|
Effective tax rate
|
20.05%
|
25.87%
|
24.71%
|
22.64%
|
|
Other operating expenses
|
208.10M
|
171.50M
|
131.80M
|
311.60M
|
|
Net income
|
197.30M
|
323.80M
|
316.60M
|
316.10M
|
|
Net profit margin
|
14.30%
|
21.11%
|
19.20%
|
18.04%
|
|
Earnings per share
|
–
|
6.54
|
7.29
|
7.96
|
|
Interest and investment income
|
–
|
–
|
–
|
–
|
|
Interest expense
|
-50.40M
|
-61.90M
|
-53.30M
|
-84.60M
|
|
Net interest expenses
|
-50.40M
|
-61.90M
|
-53.30M
|
-84.60M
|
|
Depreciation and amortization charges
|
59.90M
|
80.90M
|
78.60M
|
93.00M
|
|
EBITDA
|
323.90M
|
484.55M
|
499.80M
|
460.03M
|
|
Gain or loss from assets sale
|
–
|
–
|
–
|
–
|
Read Also:- TruAlt Bioenergy Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Hi, I’m Ronak, a news writer covering the latest updates in automobiles, education, smartphones, and trending topics. I focus on delivering simple, clear, and timely news to keep readers informed about what’s happening around the world.